187 results on '"Crozier, Robert A."'
Search Results
2. Safety and efficacy of viltolarsen in ambulatory and nonambulatory males with Duchenne muscular dystrophy
3. Carnosic acid inhibits secretion of allergic inflammatory mediators in IgE-activated mast cells via direct regulation of Syk activation
4. The Electrophysiological Signature of Spiral Ganglion Neurons
5. Brain-Derived Neurotrophic Factor Modulates Hippocampal Synaptic Transmission by Increasing N-methyl-D-Aspartic Acid Receptor Activity
6. Better Understanding and Recognition of the Disconnects, Experiences, and Needs of Patients with Irritable Bowel Syndrome with Constipation (BURDEN IBS-C) Study: Results of an Online Questionnaire
7. Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials
8. JNK signaling during IL-3-mediated differentiation contributes to the c-kit-potentiated allergic inflammatory capacity of mast cells
9. Prescribing Patterns and Outcomes of Edoxaban in Atrial Fibrillation: One-Year Data from the Global ETNA-AF Program
10. Acute activation of SERCA with CDN1163 attenuates IgE ‐mediated mast cell activation through selective impairment of ROS and p38 signaling
11. Targeting glycogen synthase kinase 3 with CHIR99021 negatively regulates allergen‐induced mast cell activation
12. Dynamic firing properties of type I spiral ganglion neurons
13. Zika Virus Replication in a Mast Cell Model is Augmented by Dengue Virus Antibody-Dependent Enhancement and Features a Selective Immune Mediator Secretory Profile
14. Binding of Rapamycin Analogs to Calcium Channels and FKBP52 Contributes to Their Neuroprotective Activities
15. Deprivation-Induced Synaptic Depression by Distinct Mechanisms in Different Layers of Mouse Visual Cortex
16. Amplification of input differences by dynamic heterogeneity in the spiral ganglion
17. The Electrophysiological Signature of Spiral Ganglion Neurons
18. GSK3 inhibition improves skeletal muscle function and whole-body metabolism in the severe DBA/2J mdx mouse model
19. Trusting a gut feeling: the potential of a newly refined human intestinal enteroid model to evaluate viral‐host interactions
20. Targeting glycogen synthase kinase 3 with CHIR99021 negatively regulates allergen‐induced mast cell activation.
21. Deficit Financing and Inflation: A Review of the Evidence
22. Analog Transmission of Action Potential Fine Structure in Spiral Ganglion Axons
23. Glycogen synthase kinase 3 (GSK3) is a critical regulator of allergen-mediated mast cell activation
24. Tafazzin Modulates Allergen-Induced Mast Cell Inflammatory Mediator Secretion
25. Zika virus infection of mast cells is not associated with a degranulation response
26. TAK1 contributes to IgE-FcɛRI-mediated calcium mobilization and mast cell degranulation
27. Modulated MAPK signaling during mast cell differentiation promotes an impaired inflammatory phenotype
28. Attenuation of mast cell degranulation and pro-inflammatory cytokine release by rosemary extract and carnosic acid
29. TAK1 ng aim at mechanisms of allergic inflammation: contribution of TAK1 activity in allergen‐mediated mast cell activation
30. Carnosic acid inhibits mast cell pro‐inflammatory mediator release in allergic inflammation
31. Inhibition of JNK Signaling During Mast Cell Differentiation Promotes Altered Cytokine Secretion and Degranulation Profiles
32. Mast Cell Infection by Zika Virus and Augmentation by Pre‐existing Dengue Virus Immunity
33. Tafazzin contributes to IgE‐mediated mast cell degranulation and cytokine secretion
34. Attenuation of allergen-mediated mast cell activation by rosemary extract (Rosmarinus officinalis L.)
35. Role for A Kinase-anchoring Proteins (AKAPS) in Glutamate Receptor Trafficking and Long Term Synaptic Depression
36. Ubiquitination Regulates PSD-95 Degradation and AMPA Receptor Surface Expression
37. Analog transmission of action potential fine structure in spiral ganglion axons.
38. TAK1 signaling activity links the mast cell cytokine response and degranulation in allergic inflammation
39. Mo1541 – Plecanatide Improved Patient Global Rating of IBS Symptoms and Quality of Life in Adult Patients with Ibs-C
40. Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation
41. Evaluation of the Safety and Tolerability of Plecanatide in CIC and IBS-C Patients Aged 65 and Older
42. Su1192 - Safety, Tolerability, and Effectiveness of Plecanatide in Patients with Constipation-Predominant Irritable Bowel Syndrome: Long-Term Evidence from an Open-Label Study
43. Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation.
44. Development and evolution of the national accounts: `this great invention of the 20th century'
45. P1-238: Soluble Aβ from PSAPP mice is different to that extracted from Alzheimer patients
46. Readers report.
47. P4-052: Dissociation of synaptic dysfunction and behavior in a tauopathy mouse model (PrP-MAPT) of Alzheimer's disease
48. BDNF Modulation of NMDA Receptors Is Activity Dependent
49. P2-178: Age-related synaptic dysfunction in a tauopathy mouse model (PrP-MAPT) of Alzheimer's disease
50. Binding of novel rapamycin analogs to calcium channels and FKBP52 contributes to their neuroprotective activities
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.